Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics is a research paper published in Pharmaceutics (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R01AI090810
National Institute of Allergy and Infectious Diseases
Grant: R01AI120670
National Institute of Allergy and Infectious Diseases
Grant: S10OD016226
National Institutes of Health
Grant: 5R01AI120670-04
Aerosol spectinamide-1599 therapy against tuberculosis
National Institutes of Health
Grant: 1S10OD016226-01A1
Mass Spectrometer for Small Molecule Drug Development
National Institutes of Health
Grant: 5R01AI090810-08
Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis
Fields of Study
Keywords